Family Care Hospitals Adjusts Valuation Amid Unique Financial Metrics and Market Positioning
Family Care Hospitals, a microcap in healthcare services, has adjusted its valuation, showcasing a low PE ratio of 0.82 and an impressive ROCE of 164.40%. Compared to peers with higher valuations, Family Care's metrics highlight its unique market position, despite recent stock performance fluctuations.
Family Care Hospitals, a microcap player in the healthcare services sector, has recently undergone a valuation adjustment. The company's financial metrics reveal a PE ratio of 0.82 and an EV to EBITDA ratio of 0.98, indicating a unique position within its industry. Notably, Family Care boasts a remarkable return on capital employed (ROCE) of 164.40% and a return on equity (ROE) of 219.63%, showcasing its operational efficiency and profitability.In comparison to its peers, Family Care's valuation metrics stand out. For instance, KMC Specialty and Asarfi Hospital exhibit significantly higher PE ratios of 49.58 and 27.11, respectively, while Hemant Surgical and Lotus Eye Hospital are positioned at even higher valuation levels. This contrast highlights Family Care's distinct market positioning amid a competitive landscape.
Despite recent fluctuations in stock performance, with a current price of 4.47 and a 52-week range between 3.40 and 7.73, the company's returns have lagged behind broader market indices like the Sensex over various time frames. This evaluation revision reflects the ongoing dynamics within the healthcare services industry, emphasizing the need for continued observation of market trends and peer performance.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
